Elite Pharma Price Prediction
| ELTPDelisted Stock | USD 0.04 0 6.75% |
Oversold Vs Overbought
61
Oversold | Overbought |
Using Elite Pharma hype-based prediction, you can estimate the value of Elite Pharma from the perspective of Elite Pharma response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Elite Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Elite Pharma to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Elite because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Elite Pharma after-hype prediction price | USD 0.04 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Elite |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Elite Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Elite Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Elite Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Elite Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Elite Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Elite Pharma Estimiated After-Hype Price Volatility
In the context of predicting Elite Pharma's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Elite Pharma's historical news coverage. Elite Pharma's after-hype downside and upside margins for the prediction period are 0.03 and 0.04, respectively. We have considered Elite Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Elite Pharma is very steady at this time. Analysis and calculation of next after-hype price of Elite Pharma is based on 3 months time horizon.
Elite Pharma OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Elite Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Elite Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Elite Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 2 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.04 | 0.04 | 7.24 |
|
Elite Pharma Hype Timeline
Elite Pharma is currently traded for 0.04. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Elite is anticipated to increase in value after the next headline, with the price projected to jump to 0.04 or above. The average volatility of media hype impact on the company the price is insignificant. The price gain on the next news is projected to be 7.24%, whereas the daily expected return is currently at 0.0%. The volatility of related hype on Elite Pharma is about 0.0%, with the expected price after the next announcement by competition of 0.04. The company has Profit Margin (PM) of 0.2 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.15 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.15. Given the investment horizon of 90 days the next anticipated press release will be in a few days. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate.Elite Pharma Related Hype Analysis
Having access to credible news sources related to Elite Pharma's direct competition is more important than ever and may enhance your ability to predict Elite Pharma's future price movements. Getting to know how Elite Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Elite Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AMBS | Amarantus Bioscience Holdings | 0.00 | 0 per month | 0.00 | 0.17 | 100.00 | (50.00) | 990.00 | |
| IGXT | Intelgenx Technologs | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ONCS | OncoSec Medical | (0.30) | 6 per month | 0.00 | (0.28) | 9.30 | (21.05) | 79.76 | |
| IMUC | ImmunoCellular Therapeutics | 0.00 | 0 per month | 0.00 | (0.07) | 30.16 | (15.00) | 58.21 | |
| CTSO | Cytosorbents Crp | (0.04) | 9 per month | 0.00 | (0.05) | 6.98 | (10.00) | 36.66 |
Elite Pharma Additional Predictive Modules
Most predictive techniques to examine Elite price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Elite using various technical indicators. When you analyze Elite charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Elite Pharma Predictive Indicators
The successful prediction of Elite Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Elite Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Elite Pharma based on analysis of Elite Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Elite Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Elite Pharma's related companies.
Story Coverage note for Elite Pharma
The number of cover stories for Elite Pharma depends on current market conditions and Elite Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Elite Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Elite Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Elite Pharma Short Properties
Elite Pharma's future price predictability will typically decrease when Elite Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Elite Pharma often depends not only on the future outlook of the potential Elite Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Elite Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1 B |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Elite OTC Stock
If you are still planning to invest in Elite Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Elite Pharma's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world |